FAIM
SYNH

Financial Advocates Investment Management’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Financial Advocates Investment Management’s Portfolio SYNH Stock Details SYNH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,220
Closed -$200K – 899
2022
Q3 		$200K Buy
+2,220
New +$143K 0.02% 693

Other funds holding SYNH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Financial Advocates Investment Management's SYNH Position: Q4 2022 in Review

Financial Advocates Investment Management sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q4 2022, closing a stake of 2,220 shares — an estimated $200K sold.

Financial Advocates Investment Management first reported a position in SYNH in Q3 2022 and held it in 1 quarter. The position peaked at $200K in Q3 2022. 307 funds tracked by Wall St. Rank hold SYNH as of Q4 2022.

  • Financial Advocates Investment Management reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
  • Financial Advocates Investment Management sold 2,220 Syneos Health, Inc. Class A Common Stock shares in Q4 2022, an estimated $200K.
  • Financial Advocates Investment Management first reported a position in Syneos Health, Inc. Class A Common Stock in Q3 2022 and held it in 1 quarter.
  • Financial Advocates Investment Management's Syneos Health, Inc. Class A Common Stock position peaked at $200K in Q3 2022.
  • 307 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q4 2022.

Based on Financial Advocates Investment Management's 13F filing for Q4 2022, filed 15 Feb 2023.